Notably, CDK1 inhibition significantly reduced the levels of genomic instability, underlining that premature entry induced by ATR inhibition drives genomic instability in PARP inhibitor‐treated BRCA2‐depleted cancer cells. Here, CDK1 is linked to cancer.